Iovance Biotherapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

Go back to Iovance Biotherapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update
(NASDAQ: IOVA) Delayed: 10.02 +0.15 (1.52%)
Previous Close $9.87    52 Week High
Open $10.25    52 Week Low
Day High $10.98    P/E N/A 
Day Low $9.99    EPS
Volume 24,195,783